<- Go Home
Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company has a collaboration with SkyWaterTechnology for the development of consumable for Proteus, that will enable simultaneous protein sequencing. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Market Cap
$354.4M
Volume
707.4K
Cash and Equivalents
$42.3M
EBITDA
-$96.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.2M
Profit Margin
51.54%
52 Week High
$5.77
52 Week Low
$0.61
Dividend
N/A
Price / Book Value
1.32
Price / Earnings
-3.08
Price / Tangible Book Value
1.32
Enterprise Value
$171.9M
Enterprise Value / EBITDA
-1.88
Operating Income
-$101.1M
Return on Equity
35.79%
Return on Assets
-22.80
Cash and Short Term Investments
$196.3M
Debt
$13.8M
Equity
$210.5M
Revenue
$2.3M
Unlevered FCF
-$50.3M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium